Kavar Capital Partners Group’s Merck MRK Stock Holding History

Kavar Capital Partners Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Buy	16,019 +155	+1%	+$18.1K	0.25%	77
2026 Q1	$1.91M	Sell	15,864 -10	-0.1%	-$1.15K	0.24%	81
2025 Q4	$1.67M	Sell	15,874 -454	-3%	-$42.6K	0.23%	81
2025 Q3	$1.37M	Sell	16,328 -103	-0.6%	-$8.48K	0.18%	91
2025 Q2	$1.3M	Sell	16,431 -99	-0.6%	-$7.87K	0.19%	94
2025 Q1	$1.48M	Sell	16,530 -132	-0.8%	-$12.3K	0.25%	82
2024 Q4	$1.66M	Sell	16,662 -489	-3%	-$50.4K	0.28%	78
2024 Q3	$1.95M	Sell	17,151 -148	-0.9%	-$17.6K	0.31%	75
2024 Q2	$2.14M	Sell	17,299 -40	-0.2%	-$5.15K	0.39%	65
2024 Q1	$2.29M	Sell	17,339 -9,523	-35%	-$1.17M	0.42%	63
2023 Q4	$2.93M	Buy	26,862 +12,173	+83%	+$1.26M	0.33%	71
2023 Q3	$1.51M	Sell	14,689 -354	-2%	-$38.2K	0.33%	73
2023 Q2	$1.74M	Sell	15,043 -4	-0%	-$454	0.37%	70
2023 Q1	$1.6M	Sell	15,047 -147	-1%	-$15.9K	0.35%	72
2022 Q4	$1.69M	Sell	15,194 -888	-6%	-$90.8K	0.39%	68
2022 Q3	$1.39M	Sell	16,082 -1,147	-7%	-$102K	0.35%	71
2022 Q2	$1.57M	Buy	17,229 +128	+0.7%	+$11.3K	0.36%	69
2022 Q1	$1.4M	Buy	17,101 +25	+0.1%	+$1.97K	0.3%	79
2021 Q4	$1.31M	Sell	17,076 -565	-3%	-$45K	0.27%	82
2021 Q3	$1.32M	Buy	17,641 +275	+2%	+$20.9K	0.3%	80
2021 Q2	$1.35M	Sell	17,366 -1,305	-7%	-$97.1K	0.33%	81
2021 Q1	$1.37M	Buy	18,671 +3,563	+24%	+$263K	0.37%	72
2020 Q4	$1.18M	Buy	15,108 +870	+6%	+$66.5K	0.34%	73
2020 Q3	$1.13M	Buy	14,238 +1,332	+10%	+$104K	0.38%	67
2020 Q2	$952K	Buy	12,906 +8,829	+217%	+$665K	0.37%	69
2020 Q1	$299K	Buy	4,077 +53	+1%	+$4.17K	0.14%	93
2019 Q4	$349K	Sell	4,024 -210	-5%	-$17.2K	0.13%	96
2019 Q3	$340K	Hold	4,234	–	–	0.13%	101
2019 Q2	$339K	Sell	4,234 -183	-4%	-$14K	0.13%	96
2019 Q1	$351K	Buy	4,417 +274	+7%	+$20.5K	0.16%	97
2018 Q4	$302K	Sell	4,143 -40	-1%	-$2.82K	0.16%	84
2018 Q3	$283K	Sell	4,183 -628	-13%	-$40K	0.14%	87
2018 Q2	$279K	Sell	4,811 -210	-4%	-$11.8K	0.14%	90
2018 Q1	$261K	Hold	5,021	–	–	0.14%	95
2017 Q4	$270K	Sell	5,021 -838	-14%	-$46.5K	0.14%	91
2017 Q3	$358K	Hold	5,859	–	–	0.2%	86
2017 Q2	$358K	Hold	5,859	–	–	0.19%	89
2017 Q1	$355K	Buy	5,859 +1,781	+44%	+$108K	0.2%	90
2016 Q4	$229K	Buy	4,078 +37	+0.9%	+$2.17K	0.14%	92
2016 Q3	$241K	Hold	4,041	–	–	0.16%	93
2016 Q2	$222K	Sell	4,041 -419	-9%	-$22.3K	0.14%	97
2016 Q1	$225K	Hold	4,460	–	–	0.15%	95
2015 Q4	$224K	Hold	4,460	–	–	0.14%	99
2015 Q3	$210K	Sell	4,460 -210	-4%	-$11.2K	0.15%	101
2015 Q2	$253K	Hold	4,670	–	–	0.17%	107
2015 Q1	$256K	Sell	4,670 -70	-1%	-$3.96K	0.22%	94
2014 Q4	$257K	Hold	4,740	–	–	0.2%	114
2014 Q3	$268K	Hold	4,740	–	–	0.23%	109
2014 Q2	$262K	Hold	4,740	–	–	0.22%	115
2014 Q1	$256K	Hold	4,740	–	–	0.21%	113
2013 Q4	$226K	Buy	+4,740	New	+$217K	0.2%	110

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kavar Capital Partners Group's MRK Position: Q2 2026 in Review

Kavar Capital Partners Group increased its Merck (MRK) stake by 0.98% in Q2 2026, buying an estimated $18.1K and bringing the position to 16,019 shares worth $2.06M. The position accounts for 0.25% of the portfolio, ranked #77.

Kavar Capital Partners Group first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.93M in Q4 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Kavar Capital Partners Group held 16,019 shares of Merck worth $2.06M as of Q2 2026.
Kavar Capital Partners Group bought 155 Merck shares in Q2 2026, an estimated $18.1K.
Merck made up 0.25% of Kavar Capital Partners Group's portfolio in Q2 2026, its #77 holding.
Kavar Capital Partners Group first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
Kavar Capital Partners Group's Merck position peaked at $2.93M in Q4 2023.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.